These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


353 related items for PubMed ID: 12086405

  • 1. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM.
    J Environ Pathol Toxicol Oncol; 2002; 21(2):183-91. PubMed ID: 12086405
    [Abstract] [Full Text] [Related]

  • 2. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
    Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ.
    Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.
    Müller-Decker K.
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 5. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS, Surh YJ.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405
    [Abstract] [Full Text] [Related]

  • 6. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study.
    Athar M, An KP, Morel KD, Kim AL, Aszterbaum M, Longley J, Epstein EH, Bickers DR.
    Biochem Biophys Res Commun; 2001 Feb 02; 280(4):1042-7. PubMed ID: 11162632
    [Abstract] [Full Text] [Related]

  • 7. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS, Rao CV.
    J Environ Pathol Toxicol Oncol; 2002 Feb 02; 21(2):155-64. PubMed ID: 12086402
    [Abstract] [Full Text] [Related]

  • 8. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 9. A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis.
    Rundhaug JE, Mikulec C, Pavone A, Fischer SM.
    Mol Carcinog; 2007 Aug 15; 46(8):692-8. PubMed ID: 17443745
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 11. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
    Iñiguez MA, Punzón C, Fresno M.
    J Immunol; 1999 Jul 01; 163(1):111-9. PubMed ID: 10384106
    [Abstract] [Full Text] [Related]

  • 12. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B.
    J Oral Pathol Med; 2004 Nov 01; 33(10):607-13. PubMed ID: 15482327
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
    Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM.
    Mol Carcinog; 2003 Oct 01; 38(2):49-58. PubMed ID: 14502644
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.
    Pentland AP, Scott G, VanBuskirk J, Tanck C, LaRossa G, Brouxhon S.
    Cancer Res; 2004 Aug 15; 64(16):5587-91. PubMed ID: 15313895
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of cyclooxygenase-2 in the pathogenesis of skin cancer.
    Brecher AR.
    J Drugs Dermatol; 2002 Jul 15; 1(1):44-7. PubMed ID: 12847753
    [Abstract] [Full Text] [Related]

  • 17. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR, DuBois RN.
    J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandins and the regulation of tumor growth.
    Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Mitchell JA.
    J Environ Pathol Toxicol Oncol; 2002 Apr 20; 21(2):93-101. PubMed ID: 12086407
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.